CXCL8 and ovarian carcinoma: In ovarian cancer cells in vitro, the BZ increased IL-8 expression is mediated by IKKβ-dependent recruitment of S536-phosphorylated p65 to IL-8 promoter [27], suggesting that inhibition of IKK activity might increase BZ effectiveness in ovarian cancer.